MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-JK-07-0002760
Stranzpro Pharma (OPC) Private Limited
Stranzpro Pharma (OPC) Private Limited - chemicals in Jammu, Jammu And Kashmir, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹5.03 Lakh
▼ 48% YoY
Net profit · FY 2024
₹13,544
Net margin 2.7%
EBITDA · FY 2024
₹77,334
EBITDA margin 15.4%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹5,000
Issued & subscribed
Open charges
₹5 Lakh
Secured borrowings
Company age
7 yrs
Est. 2019
Directors on board
1
As per MCA filings
About Stranzpro Pharma (OPC) Private Limited
Data last updated:
Stranzpro Pharma (OPC) Private Limited is a one person company based in Jammu, Jammu And Kashmir, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 20 September 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Jammu, under CIN U24239JK2019OPC011192. Its GSTIN is 01ABCCS6653F1ZL (Jammu and Kashmir).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹5,000. It is led by director Supinder Deep Singh Bakshi.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O Mr.Gurdeep Singh Bakshi Niwas Swaran Colony Trilokpur Rd Gole Gujral, Jammu, Jammu and Kashmir, India – 180002.
As per the financials filed for FY 2024, the company reported a revenue of ₹5.03 Lakh, a decline of 48% compared to the previous year. For the same year it recorded a net profit of ₹13,544 (net margin 2.7%) and EBITDA of ₹77,334 (EBITDA margin 15.4%). Revenue has declined at a compounded annual rate (CAGR) of 15% over three years.
As per MCA filings, the company has open charges of ₹5 Lakh on record.
Stranzpro Pharma (OPC) Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-JK-07-0002760).
Company details
CIN U24239JK2019OPC011192
Registration Number 011192
Incorporation Date 20 September 2019
ROC Jammu
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2022
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-JK-07-0002760
Key People
Supinder Deep Singh Bakshi Director Recognitions & Rankings of Stranzpro Pharma
Contact details
Stranzpro Pharma (OPC) Private Limited's registered office is in Jammu, Jammu And Kashmir. Its e-mail address is in the company report.
- Email
- Registered AddressC/O Mr.Gurdeep Singh Bakshi Niwas Swaran Colony Trilokpur Rd Gole Gujral, Jammu, Jammu and Kashmir, India – 180002
- IndustryChemicals, Manufacturing, Other Chemical Product
To see the full contact details of Stranzpro Pharma (OPC) Private Limited, buy the company report.
Comprehensive company report
Stranzpro Pharma (OPC) Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Stranzpro Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Stranzpro Pharma (OPC) Private Limited, buy the company report.
Financials of Stranzpro Pharma (OPC) Private Limited
FY 2025 filings availableStranzpro Pharma (OPC) Private Limited reported revenue of ₹5.03 Lakh (down 48% YoY) for FY 2024.
Revenue · FY 2024
₹5.03 Lakh ▼ 48%
Net profit · FY 2024
₹13,544 margin 2.7%
EBITDA · FY 2024
₹77,334 margin 15.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 48%
3 years · compounded
▼ 15%
EBITDA CAGR growth
1 year
▲ 127%
3 years · compounded
▲ 67%
Revenue has declined at a compounded annual rate (CAGR) of 15% over three years, including a 48% fall in the latest year. EBITDA rose 127% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹77,334 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹13,544 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 15.4% | ||||
| Net Profit Margin | 2.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Stranzpro Pharma (OPC) Private Limited, buy the company report.
Board of directors of Stranzpro Pharma (OPC) Private Limited
Stranzpro Pharma has 1 director on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Supinder Deep Singh Bakshi | Director | 20 Sep 2019 | 7 Years 1 Months | Current |
Peer comparison
Stranzpro Pharma (OPC) Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Freshwis Vyapaar Limited | ₹5.03 Lakh (FY 2018) | Jaipur, Rajasthan, India | ||||
| Geomart Network Private Limited | ₹5.03 Lakh (FY 2024) | -40.0% | Thiruvarur, Tamil Nadu, India | |||
| V Solutions Matrix Private Limited | ₹5.03 Lakh (FY 2025) | -17.0% | Delhi, India | |||
| Zenith Birla Steels Private Limited | ₹5.03 Lakh (FY 2023) | -98.0% | Mumbai, Maharashtra, India | |||
| Crozal Lubricants India Private Limited | ₹5.03 Lakh (FY 2021) | -32.0% | Patna, Bihar, India | |||
| Stranzpro Pharma (OPC) Private Limitedthis company | ₹5.03 Lakh (FY 2024) | ₹13,544 | 2.7% | -48.0% | Jammu, Jammu And Kashmir, India | |
| Aps Health Care Private Limited | ₹5.03 Lakh (FY 2025) | 3.0% | New Delhi, Delhi, India | |||
| Natural and Nutritive Foods Private Limited | ₹5.03 Lakh (FY 2025) | -82.0% | New Delhi, Delhi, India | |||
| SCSD Social and Educational Foundation | ₹5.03 Lakh (FY 2023) | Mirzapursadar, Uttar Pradesh, India | ||||
| Accuracy Pharmaceutical Private Limited | ₹5.03 Lakh (FY 2024) | Bhilwara, Rajasthan, India | ||||
| Sja Trading (India) Private Limited | ₹5.03 Lakh (FY 2025) | -18.0% | New Delhi, Delhi, India |
To see the full peer comparison of Stranzpro Pharma (OPC) Private Limited, buy the company report.
Charges & borrowings
Open charges
₹5 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 27 Nov 2020 | 100398850 | Canara Bank | ₹5 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Stranzpro Pharma (OPC) Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Stranzpro Pharma (OPC) Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Stranzpro Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 01ABCCS6653F1ZL | Jammu and Kashmir | Active | 19 Aug 2020 |
To see the full GST registrations and return filing status of Stranzpro Pharma (OPC) Private Limited, buy the company report.
Recent activity
Stranzpro Pharma (OPC) Private Limited has 1 board change on record since 2019: 1 appointment. The latest: Supinder Deep Singh Bakshi was appointed as Director on 20 Sep 2019.
Filing
Stranzpro Pharma (Opc) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Jammu.
AGM
Stranzpro Pharma (Opc) Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records.
Charges
A charge with Canara Bank amounted to Rs. 5.00 Lakh with Charge ID 100398850 was registered on 27 Nov 2020.
Appointed
Supinder Deep Singh Bakshi was appointed as Director.
Incorporation
20 Sep 2019
Stranzpro Pharma (Opc) Private Limited was registered on 20 Sep 2019 with Roc Jammu & aged 7 years 1 month as per MCA records.
Frequently asked questions
Stranzpro Pharma is an active company based in Jammu, Jammu And Kashmir, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 20 September 2019 (7+ years old) and is registered under CIN U24239JK2019OPC011192.
Stranzpro Pharma has 1 current director:
- Supinder Deep Singh Bakshi - Director
The latest financial statements of Stranzpro Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2022. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Stranzpro Pharma is 01ABCCS6653F1ZL, registered in Jammu and Kashmir.
The CIN (Corporate Identification Number) of Stranzpro Pharma is U24239JK2019OPC011192. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Stranzpro Pharma was incorporated on 20 September 2019, making it 7+ years old. It is registered with the Registrar of Companies, Jammu.
The peers of Stranzpro Pharma by revenue are Freshwis Vyapaar Limited, Geomart Network Private Limited, V Solutions Matrix Private Limited, Zenith Birla Steels Private Limited, Crozal Lubricants India Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Supinder Deep Singh Bakshi was appointed as Director on 20 Sep 2019.
Yes, Stranzpro Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-JK-07-0002760).
The registered office of Stranzpro Pharma is at CO Mr.Gurdeep Singh Bakshi Niwas Swaran Colony Trilokpur Rd Gole Gujral, Jammu, Jammu and Kashmir, India – 180002.
Stranzpro Pharma operates in the chemicals industry, in the manufacturing segment.